Прогноз эффективности нейрофидбека у больных тревожными расстройствами, резистентными к психофармакотерапии
Е В Бирюкова, Sergey N Mosolov · Социальная и клиническая психиатрия · 2011
This article presents results of investigation of biofeedback (BFB) effect, that has to do with changing brain electric activity, on condition of patients with anxiety disorders resistant to psychopharmacotherapy. Material: 60 patients, of them 16 with obsessive-compulsive disorder, 16 with social phobias, 14 with mixed anxious-depressive disorders, and 14 with specific individual phobias. According to data obtained, neurofeedback seems to be an effective means for coping with therapeutic resistance in patients with anxious disorders, especially in anxious depression and in specific individual phobias. On basis of the results, a mathematical formula has been developed that predicts the efficacy of this method. An overlap between actual and predicted values is 2.99±6.4 with correlation 0.83 (р
Cited by 0 works.
Authors
References
- Chemokines, inflammation and the immune system.
- Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.
- Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
- Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review.
- Interleukin-8 secretion by cultured oral epidermoid carcinoma cells induced with nicotine and/or arecoline treatments.